<DOC>
	<DOCNO>NCT02421393</DOCNO>
	<brief_summary>Type 2 diabetes mellitus ( T2DM ) associate increased fracture risk despite normal increase bone mass , thus suggest poor bone quality . This study aim weigh effect exercise intervention program parameter bone quality patient type 2 diabetes mellitus . Two hundred patient T2DM randomize supervised exercise training top standard care ( exercise , EXE , group ; n=100 ) versus standard care ( control , CON , group ; n=100 ) 24 month .</brief_summary>
	<brief_title>Study Weigh Effect Exercise Training BONE ( SWEET-BONE ) Quality Strength Type 2 Diabetes</brief_title>
	<detailed_description>Type 2 diabetes mellitus ( T2DM ) associate increased fracture risk despite normal increase bone mass , assess bone mineral density ( BMD ) dual‐energy X‐ray absorptiometry ( DXA ) . Increased fracture risk remain adjustment BMD , also fall , frequent individual non-diabetic counterpart , due chronic complication treatment , body mass index , seem protective increase BMD . This suggest patient T2DM poor bone quality , i.e . alter bone geometry microarchitecture , result reduce strength . Based mechanostat therapy , physical activity ( PA ) /exercise would beneficial prevent fracture T2DM individual great mechanical loading skeleton , cause favorable bone adaptation , also increase muscle mass , strength , performance , reduces risk fall improve gait balance . The aim study ass effect specific exercise training intervention program parameter bone quality patient type 2 diabetes . Two hundred patient T2DM randomize supervised exercise training top standard care ( exercise , EXE , group ; n=100 ) versus standard care ( control , CON , group ; n=100 ) 24 month . Sample size calculation base recent report show TBS low diabetic vs. control subject ( 1.228 vs. 1.298 ) standard deviation 0.140 . To observe normalization TBS EXE participant statistical power 90 % ( α=0.05 ) unpaired t-test , 85 patient per arm need ( 170 total ) . A sample size 200 patient allow support dropout rate 15 % . A sample 100 non-diabetic subject match 1:2 age , gender , BMI use control baseline measure . EXE participant attend two weekly session 75 min , supervise exercise specialist dedicate gym facility . Each session include : 5 min warm ; 20 min aerobic training use treadmill ; 15 min resistance training muscle group skeletal site fragility fracture ; 15 min `` weight bearing '' exercise use weighted vest ; 8 min core stability training ; 8 min balance training ; 4 min flexibility training . Weighted vest worn also aerobic train occupational , home leisure-time PA. CON subject receive advises maintain physically active lifestyle , accord current guideline , perform type commuting , occupational , home leisure-time PA. All patient subject treatment regimen aim achieve optimal glycemic , lipid , BP body weight target , establish current guideline include glucose- , lipid- BP-lowering agent need . For ethical reason , drug also adjust throughout study attain target level account reduce need . Since patient overweight obese , caloric intake ( 55 % complex carbohydrate , 30 % fat , 15 % protein ) reduce obtain negative balance 500 kcal/day . Requirements calculate add estimate energy expenditure PA basal metabolism . Adherence diet verify use food diary dietary prescription adjust intermediate visit . Patients vitamin D level range 10 20 ng/dl treat cholecalciferol 25.000 IU every 2 week 2 month , cholecalciferol 25.000 IU every month , whereas vitamin D level range 20 30 ng/dl give cholecalciferol 25.000 IU every month . At 6 month participant , re-evaluated treatment discontinue case vitamin D value &gt; 30 ng/dl continue additional 6 month dos indicate , end study . Randomization stratify gender ( male versus female ) , age ( 65-70 versus 71-75 ) type diabetes treatment ( non-insulin versus insulin ) , use permuted-block randomization software . Physicians patient blind group assignment , variance operator execute instrumental procedure , whereas sample blind central laboratory achieve use bar code . The primary endpoint trabecular bone score ( TBS ) , derive antero-posterior spine raw DXA image ( ) region interest BMD measurement use specific software correlate three-dimensional bone micro-architecture parameter . Among numerous potential measure bone quality , TBS one consistently show low T2DM vs. control subject . Secondary endpoint include : 1. potential measure bone quality assess peripheral quantitative compute tomography ( pQCT ) quantitative ultrasound ( QUS ) ; 2. bone mass ( BMD assess DXA ) ; 3. bone metabolism ( sclerostin biochemical marker bone formation resorption ) ; 4. body composition ( total body lean fat mass total body DXA ) ; 5. muscle strength ( dynamometer ) ; 6. muscle mass/density ( pQCT ) ; 7. balance , gait power ( Short Battery Performance Test ) ; 8. musculoskeletal ( MS ) symptom ( questionnaire ) ; h. number fall ( questionnaire ) ; i. symptomatic asymptomatic fracture ( history medical record vertebral morphometry , respectively ) . Other measure include : - quality life ( QoL ) ; - cardiorespiratory fitness ; - flexibility ; - volume PA ; - coronary heart disease 10-year risk score . Dietary intake adverse event also record . Participants group follow additional 5 year order record number fall eventual fracture time period . PA MS symptom also monitor throughout 5-year interval . To end , patient see yearly ( every 6 month accord degree glycemic control overall cardiovascular risk profile ) order collect self-report data number fall type amount PA daily diary , clinical documentation eventual fracture , MS questionnaire .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>diabetes duration &gt; 5year sedentary lifestyle ( i.e . 8 hours/day spend wake behavior characterize energy expenditure ≤1.5 metabolic equivalent [ METs ] sit recline posture ) least 6 month ; physically inactivity ( i.e . insufficient amount physical activity [ PA ] accord current guideline ) least 6 month ; body mass index ( BMI ) 2740 kg/m2 ; ability walk 1.6 Km without assistance ; Short Battery Performance Test score range 4 9 ; eligibility cardiologic evaluation . condition limit participation clinical trial , include psychiatric disorder hospitalization depression past 6 month ; condition limit PA/exercise , include musculoskeletal disorder deformity , central nervous system dysfunction hemiparesis , myelopathies , cerebral ataxia , vestibular dysfunction , postural hypotension ( i.e . fall &gt; 20 mmHg systolic &gt; 10 mmHg diastolic blood pressure change position ) ; cancer lifeexpectancy limit condition ; recent major acute cardiovascular event , include heart attack , stroke/transient ischemic attack ( ) , revascularization procedure , participation cardiac rehabilitation program within past three month , document history pulmonary embolism past six month ; preproliferative proliferative retinopathy ; macroalbuminuria and/or estimate glomerular filtration rate ( eGFR ) &lt; 45 ml/min/1.73 m2 ; ankle/brachial index ( ABI ) &lt; 0.9 ; severe motor sensory neuropathy ; diabetic foot history ulcer ; hemoglobin ( Hb ) A1c &gt; 9.0 % ; blood pressure ( BP ) &gt; 150/90 mmHg ; vitamin D &lt; 10 ng/ml ; treatment antifracturative agent , estrogen , aromatase inhibitor , testosterone , corticosteroid and/or glitazon ; previous document nontraumatic fracture , total spine deformity index ( SDI ) &gt; 3 ( &gt; 1 single vertebra ) ; T score &lt; 2.5 spine/hip dual‐energy X‐ray absorptiometry ( DXA ) . Subjects HbA1c blood pressure indicate threshold receive appropriate treatment reevaluate 3 month . Patients vitamin D level &lt; 10 ng/dl treat cholecalciferol 25.000 IU/week 6 week reevaluate eligibility 2 week last</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bone quality</keyword>
	<keyword>Bone strength</keyword>
	<keyword>Fractures</keyword>
	<keyword>Muscle strength</keyword>
	<keyword>Gait balance</keyword>
	<keyword>Musculo-skeletal symptom</keyword>
	<keyword>Falls</keyword>
</DOC>